Article info

Download PDFPDF
Rituximab in thrombotic primary antiphospholipid syndrome: a pilot study from a single centre in China

Authors

  1. Correspondence to Dr Junna Ye, Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; yjn0912{at}qq.com; Dr Chengde Yang; yangchengde{at}sina.com
View Full Text

Citation

You Y, Shi C, Zhou Z, et al
Rituximab in thrombotic primary antiphospholipid syndrome: a pilot study from a single centre in China

Publication history

  • Received October 15, 2020
  • Revised January 8, 2021
  • Accepted January 9, 2021
  • First published January 15, 2021.
Online issue publication 
May 12, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.